European Lung Cancer Congress 2022

Search results (14)

14 Feb 2022

European Lung Cancer Congress 2022: Prof. Nicolas Girard tells you why you can’t miss this event

Watch video

14 Feb 2022

European Lung Cancer Congress 2022: Prof. Nicolas Girard on the key benefits of attending this event

Watch video

16 Feb 2022

European Lung Cancer Congress 2022: Prof. Lizza Hendriks tells you why you can’t miss this event

Watch video

European Lung Cancer Congress 2022

30 Mar 2022

Patient-reported outcomes are essential when their availability is prompt

By
• Massimo Di Maio - Guest editor

Read more

Lung and other thoracic tumours

31 Mar 2022

Perioperative survival after bilobectomy is worse than lobectomy

Read more

Lung and other thoracic tumours

30 Mar 2022

Encouraging results with savolitinib in NSCLC with MET exon14 skipping mutations

Read more

Cancer Immunology and Immunotherapy

31 Mar 2022

Encouraging safety data for the use of durvalumab after sequential chemotherapy in stage III unresectable NSCLC

Read more

Lung and other thoracic tumours

31 Mar 2022

Results for two new third-generation EGFR tyrosine kinase inhibitors do not suggest advantages over osimertinib

Read more

Cancer Immunology and Immunotherapy

31 Mar 2022

Atezolizumab shows little heterogeneity in efficacy in high PD-L1 expressers with stage II–IIIA NSCLC

Read more

Lung and other thoracic tumours

31 Mar 2022

Assessing pathological response after neoadjuvant treatment for NSCLC

Much progress has been made in the standardisation of pathological response but optimising viable tumour cutoffs for predicting long-term outcome after different treatment modalities and by histological type remain key areas for investigation 

By William Travis

Read more